Whole-Genome Sequencing of Salmonella Mississippi and Typhimurium Definitive Type 160, Australia and New Zealand
Laura Ford, Danielle Ingle, Kathryn Glass, Mark Veitch, Deborah A. Williamson, Michelle Harlock, Joy Gregory, Russell Stafford, Nigel French, Samuel Bloomfield, Zoe Grange, Mary Lou Conway, and Martyn D. Kirk
Author affiliations: The Australian National University, Acton, Australian Capital Territory, Australia (L. Ford, D. Ingle, K. Glass, M.D. Kirk); The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (D. Ingle, D.A. Williamson); Department of Health, Hobart, Tasmania, Australia (M. Veitch, M. Harlock); Victorian Department of Health and Human Services, Melbourne (J. Gregory); Queensland Department of Health, Brisbane, Queensland, Australia (R. Stafford); New Zealand Food Safety Science and Research Centre, Manawatu-Wanganui, New Zealand (N. French); Massey University, Manawatu-Wanganui (N. French); Quadram Institute, Norwich, UK (S. Bloomfield); University of California Davis–Davis, California, USA (Z. Grange); Department of Primary Industries, Parks, Water and Environment, Hobart (M.L. Conway)
Figure 2. Notification rates for Salmonella enterica serovar Mississippi, Tasmania (A) and mainland Australia and New Zealand (B), 2000–2016. Rates are per 100,000 population.
Page created: August 20, 2019
Page updated: August 20, 2019
Page reviewed: August 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.